covered entities; 340B drugs; distribution

Summary

The bill bars drug manufacturers and repackagers from refusing 340B drugs to covered entities or their contracted pharmacies, and from requiring claims or utilization data as a condition for delivery, unless required by federal law. Violations can be investigated by the state board and enforced by the attorney general, but individuals cannot sue privately. It aims to protect the flow of discounted drugs to safety‑net providers.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share